Product image of Levebon (Levetiracetam) supplied by GNH India

Levebon

Active Ingredient:
Levetiracetam
Origin:
EU

Levebon (Levetiracetam)

Levetiracetam, the active ingredient in Levebon, is an anticonvulsant presented as an intravenous solution for intravenous use. It is indicated for the management of epilepsy and helps reduce the frequency of seizures in adult and pediatric patients who require parenteral therapy. The medication is formulated for hospital settings where rapid plasma concentrations are needed.

GNH India supplies Levebon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable access to this essential antiepileptic agent. Our distribution network ensures timely delivery and compliance with local regulations.

Manufacturer / TM Owner

G.L. Pharma Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Levetiracetam is an anticonvulsant used to control seizures in epilepsy.

  • Partial‑onset seizures: reduces seizure frequency in patients with focal epilepsy.
  • Generalized tonic‑clonic seizures: provides adjunctive control in generalized epilepsy.
  • Myoclonic seizures: helps manage seizure activity in specific epilepsy syndromes.

How It Works

  • Levetiracetam binds selectively to the synaptic vesicle protein SV2A, modulating neurotransmitter release. This interaction stabilizes neuronal membranes and reduces hyper‑excitability, thereby decreasing the likelihood of seizure propagation across neuronal networks.

Side Effects

Levetiracetam may cause a range of adverse reactions.

Common Side Effects

  • Fatigue: feeling of tiredness or lack of energy.
  • Dizziness: sensation of light‑headedness or unsteadiness.
  • Somnolence: increased sleepiness or drowsiness.
  • Headache: mild to moderate pain in the head region.
  • Irritability: mood changes including agitation.
  • Nausea: feeling of stomach upset.

Serious or Rare Side Effects

  • Severe allergic reaction: rash, swelling, or difficulty breathing.
  • Stevens‑Johnson syndrome: rare skin disorder with blistering.
  • Suicidal ideation: thoughts of self‑harm or suicide.
  • Blood dyscrasias: abnormal blood counts or clotting issues.
  • Severe depression: marked mood disturbances requiring medical attention.
  • Hepatic failure: signs of liver dysfunction such as jaundice.

Precautions & Warnings

When using Levebon, consider the following safety measures.

  • Renal impairment: adjust dosing and monitor renal function.
  • Hepatic dysfunction: evaluate liver enzymes before and during therapy.
  • Psychiatric symptoms: observe for mood changes, depression, or suicidal thoughts.
  • Concomitant CNS depressants: use with caution due to additive sedation.
  • Pregnancy: risk unknown; weigh benefits against potential hazards.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Avoid Interactions

Levetiracetam may interact with other medicines; monitor accordingly.

Major Interactions (Avoid)

  • Carbamazepine: may lower levetiracetam plasma concentrations.
  • Phenobarbital: can reduce therapeutic effect of levetiracetam.
  • Topiramate: increased risk of central nervous system depression.

Moderate Interactions (Monitor Closely)

  • Alcohol: may enhance sedative effects.
  • Other antiepileptics: dose adjustments may be required based on clinical response.

Frequently Asked Questions

Levebon contains levetiracetam, an antiepileptic medication used to control various types of seizures in patients with epilepsy. It is administered intravenously in hospital settings to achieve rapid therapeutic levels when oral administration is not feasible.

Levetiracetam binds to the synaptic vesicle protein SV2A, which modulates neurotransmitter release. This action stabilizes neuronal firing and reduces hyper‑excitability, helping to prevent the spread of seizure activity throughout the brain.

The dosage of Levebon is determined by the prescribing clinician based on the patient’s age, weight, renal function, and seizure type. Only a qualified healthcare professional should set the appropriate dosing regimen.

Safety data for levetiracetam in pregnancy and lactation are limited. The prescribing physician must evaluate the potential benefits against possible risks to the fetus or infant before initiating therapy.

To order Levebon, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Levebon (levetiracetam) offers a distinct mechanism by targeting SV2A, which differs from sodium‑channel blockers like carbamazepine. It is generally well tolerated, has fewer drug‑enzyme interactions, and can be administered intravenously for rapid seizure control, making it a useful alternative in acute settings.

Levebon should be stored at 2‑8 °C, protected from light, and must not be frozen. Keep the product in its original packaging to maintain stability and prevent contamination.

Levebon is given as an intravenous infusion by a qualified healthcare professional. The infusion rate and total daily dose are individualized according to the patient’s clinical condition and response to therapy.

Serious risks include severe allergic reactions, Stevens‑Johnson syndrome, suicidal thoughts or behavior, significant depression, blood disorders, and rare cases of hepatic failure. Patients should be monitored closely for any of these adverse events.

Levebon is contraindicated in patients with known hypersensitivity to levetiracetam or any of the formulation components. Caution is advised for individuals with severe renal impairment, uncontrolled psychiatric conditions, or those taking interacting medications listed under major interactions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Levetiracetam

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT